{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T20:15:33Z","timestamp":1792700133371,"version":"4.5.0"},"reference-count":128,"publisher":"Bentham Science Publishers Ltd.","issue":"5","content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDR"],"published-print":{"date-parts":[[2019,8,20]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>The incidence of diabetes is increasing steeply; the number of diabetics has doubled over the past three decades. Surprisingly, the knowledge of type 3c diabetes mellitus (T3cDM) is still unclear to the researchers, scientist and medical practitioners, leading towards erroneous diagnosis, which is sometimes misdiagnosed as type 1 diabetes mellitus (T1DM), or more frequently type 2 diabetes mellitus (T2DM). This review is aimed to outline recent information on the etiology, pathophysiology, diagnostic procedures, and therapeutic management of T3cDM patients.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>The literature related to T3cDM was thoroughly searched from the public domains and reviewed extensively to construct this article. Further, existing literature related to the other forms of diabetes is reviewed for projecting the differences among the different forms of diabetes. Detailed and updated information related to epidemiological evidence, risk factors, symptoms, diagnosis, pathogenesis and management is structured in this review.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>T3cDM is often misdiagnosed as T2DM due to the insufficient knowledge differentiating between T2DM and T3cDM. The pathogenesis of T3cDM is explained which is often linked to the history of chronic pancreatitis, pancreatic cancer. Inflammation, and fibrosis in pancreatic tissue lead to damage both endocrine and exocrine functions, thus leading to insulin\/glucagon insufficiency and pancreatic enzyme deficiency.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion:<\/jats:title><jats:p>Future advancements should be accompanied by the establishment of a quick diagnostic tool through the understanding of potential biomarkers of the disease and newer treatments for better control of the diseased condition.<\/jats:p><\/jats:sec>","DOI":"10.2174\/1573399815666190115145702","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T11:22:41Z","timestamp":1547637761000},"page":"382-394","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":61,"title":["Type-3c Diabetes Mellitus, Diabetes of Exocrine Pancreas - An Update"],"prefix":"10.2174","volume":"15","author":[{"given":"Subrat Kumar","family":"Bhattamisra","sequence":"first","affiliation":[{"name":"Department of Life Sciences, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiew Chin","family":"Siang","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chieng Yi","family":"Rong","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveenya Chetty","family":"Annan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Ho Yung","family":"Sean","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lim Wen","family":"Xi","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ong Siu","family":"Lyn","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liew Hui","family":"Shan","sequence":"additional","affiliation":[{"name":"School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hira","family":"Choudhury","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manisha","family":"Pandey","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Technology, School of Pharmacy, International Medical University, Bukit Jalil 57000, Kuala Lumpur, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bapi","family":"Gorain","sequence":"additional","affiliation":[{"name":"School of Pharmacy, Taylor\u2019s University, 1, Jalan Taylors, 47500 Subang Jaya, Selangor, Malaysia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","reference":[{"key":"ref=1","year":"2017","unstructured":"International Diabetes Federation. IDF diabetes atlas.8th ed. Brussels Belgium: International Diabetes Federation; Available from: [Cited: 1st June 2018].2017","journal-title":"Brussels Belgium: International Diabetes Federation;"},{"key":"ref=2","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.2337\/dc12-s064","volume":"35","year":"2012","unstructured":"American Diabetes Association AD. Diagnosis and classification of diabetes mellitus. Diabetes Care 2012,35(Suppl. 1),S64-S71","journal-title":"Diabetes Care"},{"key":"ref=3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.pan.2017.06.007","volume":"17","author":"Petrov M.S.","year":"2017","unstructured":"Petrov M.S.; Diabetes of the exocrine pancreas: American Diabetes Association-compliant lexicon. Pancreatology 2017,17(4),523-526","journal-title":"Pancreatology"},{"key":"ref=4","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.2337\/dc17-0542","volume":"40","author":"Woodmansey C.","year":"2017","unstructured":"Woodmansey C.; McGovern A.P.; McCullough K.A.; Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (Type 3c): a retrospective cohort study. Diabetes Care 2017,40(11),1486-1493","journal-title":"Diabetes Care"},{"key":"ref=5","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1024\/1661-8157.98.20.1135","author":"Henzen C.","year":"2009","unstructured":"Henzen C.; Secondary forms of diabetes mellitus. Praxis 2009,1135-1140","journal-title":"Praxis"},{"key":"ref=6","first-page":"211","author":"Alberti KGMM.","year":"1988","unstructured":"Alberti KGMM.; Diabetes secondary to pancreatopathy: an example of brittle diabetes. Amsterdam: Excerpta Medica Diabetes secondary to pancreatopathy proceedings of the post easd international symposium on diabetes secondary to pancreatopathy, Padova, 21-22 September 1987, International Congress Series 762.1988,211-4","journal-title":"Amsterdam: Excerpta Medica"},{"key":"ref=7","doi-asserted-by":"crossref","first-page":"7276","DOI":"10.3748\/wjg.v19.i42.7276","volume":"19","author":"Ewald N.","year":"2013","unstructured":"Ewald N.; Hardt P.D.; Diagnosis and treatment of diabetes mellitus in chronic pancreatitis. World J Gastroenterol 2013,19(42),7276","journal-title":"World J Gastroenterol"},{"key":"ref=8","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1002\/dmrr.2260","volume":"28","author":"Ewald N.","year":"2012","unstructured":"Ewald N.; Kaufmann C.; Raspe A.; Prevalence of diabetes mellitus secondary to pancreatic diseases (type 3c). Diabetes Metab Res Rev 2012,28(4),338-342","journal-title":"Diabetes Metab Res Rev"},{"key":"ref=9","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2468-1253(16)30106-6","volume":"1","author":"Hart P.A.","year":"2016","unstructured":"Hart P.A.; Bellin M.D.; Andersen D.K.; Type 3c (pancreatogenic) diabetes mellitus secondary to chronic pancreatitis and pancreatic cancer. Lancet Gastroenterol Hepatol 2016,1(3),226-237","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref=10","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/ajg.2015.356","volume":"110","author":"Shen H.N.","year":"2015","unstructured":"Shen H.N.; Yang C.C.; Chang Y.H.; Lu C.L.; Li C.Y.; Risk of diabetes mellitus after first attack acute pancreatitis: a national population-based study. Am J Gastroenterol 2015,110(12),1698","journal-title":"Am J Gastroenterol"},{"key":"ref=11","volume":"95","author":"Lee Y.K.","year":"2016","unstructured":"Lee Y.K.; Huang M.Y.; Hsu C.Y.; Su Y.C.; Bidirectional relationship between diabetes and acute pancreatitis: a population-based cohort study in Taiwan. Medicine 2016,95(2)","journal-title":"Medicine"},{"key":"ref=12","doi-asserted-by":"crossref","first-page":"540e4.","DOI":"10.1016\/j.dld.2016.12.010","volume":"49:","author":"Pendharkar SA","year":"2017","unstructured":"Pendharkar SA; Mathew J; Petrov MS; Age- and sex-specific prevalence of diabetes associated with diseases of the exocrine pancreas: a population based study. Dig Liver Dis 2017,49:,540e4.","journal-title":"Dig Liver Dis"},{"key":"ref=13","author":"Keller J.","year":"2015","unstructured":"Keller J.; Layer P.; Diagnosis of pancreatic exocrine insufficiency in chronic pancreatitis. Pancreapedia: Exocrine pancreas knowledge base Available from: [Cited 28th May 2018].2015","journal-title":"Pancreapedia: Exocrine pancreas knowledge base"},{"key":"ref=14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrd4275","volume":"13","author":"Donath M.Y.","year":"2014","unstructured":"Donath M.Y.; Targeting inflammation in the treatment of type 2 diabetes: time to start. Nat Rev Drug Discov 2014,13(6),465-476","journal-title":"Nat Rev Drug Discov"},{"key":"ref=15","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/1097-0142(19910115)67:2<486::AID-CNCR2820670228>3.0.CO;2-1","volume":"67","author":"Cersosimo E.","year":"1991","unstructured":"Cersosimo E.; Pisters P.W.; Pesola G.; McDermott K.; Bajorunas D.; Brennan M.F.; Insulin secretion and action in patients with pancreatic cancer. Cancer 1991,67(2),486-493","journal-title":"Cancer"},{"key":"ref=16","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1053\/j.gastro.2008.01.039","volume":"134","author":"Pannala R.","year":"2008","unstructured":"Pannala R.; Leirness J.B.; Bamlet W.R.; Basu A.; Petersen G.M.; Chari S.T.; Prevalence and clinical profile of pancreatic cancer-associated diabetes mellitus. Gastroenterology 2008,134(4),981-987","journal-title":"Gastroenterology"},{"key":"ref=17","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/0261-5614(93)90243-W","volume":"12","author":"Permert J.","year":"1993","unstructured":"Permert J.; Liu J.; Larsson J.; Adrian T.E.; Is impaired insulin-receptor binding involved in the impaired glucose metabolism and cachexia of pancreatic cancer patients? Clin Nutr 1993,12,31","journal-title":"Clin Nutr"},{"key":"ref=18","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0002-9610(05)80405-2","volume":"165","author":"Permert J.","year":"1993","unstructured":"Permert J.; Adrian T.E.; Jacobsson P.; Jorfelt L.; Fruin A.B.; Larsson J.; Is profound peripheral insulin resistance in patients with pancreatic cancer caused by a tumor-associated factor? Am J Surg 1993,165(1),61-67","journal-title":"Am J Surg"},{"key":"ref=19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1053\/j.gastro.2007.10.040","volume":"134","author":"Chari S.T.","year":"2008","unstructured":"Chari S.T.; Leibson C.L.; Rabe K.G.; Pancreatic cancer-associated diabetes mellitus: prevalence and temporal association with diagnosis of cancer. Gastroenterology 2008,134(1),95-101","journal-title":"Gastroenterology"},{"key":"ref=20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.pan.2012.02.003","volume":"12","author":"Aggarwal G.","year":"2012","unstructured":"Aggarwal G.; Rabe K.G.; Petersen G.M.; Chari S.T.; New-onset diabetes in pancreatic cancer: A study in the primary care setting. Pancreatology 2012,12(2),156-161","journal-title":"Pancreatology"},{"key":"ref=21","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1053\/gast.2001.27210","volume":"121","author":"Chari S.T.","year":"2001","unstructured":"Chari S.T.; Klee G.G.; Miller L.J.; Raimondo M.; DiMagno E.P.; Islet amyloid polypeptide is not a satisfactory marker for detecting pancreatic cancer. Gastroenterology 2001,121(3),640-645","journal-title":"Gastroenterology"},{"key":"ref=22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1056\/NEJM199407143310203","volume":"331","author":"Gullo L.","year":"1994","unstructured":"Gullo L.; Pezzilli R.; Morselli-Labate A.M.; Group the IPCS. Diabetes and the Risk of Pancreatic Cancer. N Engl J Med 1994,331(2),81-84","journal-title":"N Engl J Med"},{"key":"ref=23","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1053\/gast.2000.19286","volume":"119","author":"Malka D.","year":"2000","unstructured":"Malka D.; Hammel P.; Sauvanet A.; Risk factors for diabetes mellitus in chronic pancreatitis. Gastroenterology 2000,119(5),1324-1332","journal-title":"Gastroenterology"},{"key":"ref=24","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1097\/MPA.0000000000000609","volume":"45","author":"Mohapatra S.","year":"2016","unstructured":"Mohapatra S.; Majumder S.; Smyrk T.C.; Diabetes mellitus is associated with an exocrine pancreatopathy. Pancreas 2016,45(8),1104-1110","journal-title":"Pancreas"},{"key":"ref=25","doi-asserted-by":"publisher","DOI":"10.1097\/MPA.0b013e3182a 9ad9d.","volume":"42","author":"Andersen DK","year":"2013","unstructured":"Andersen DK; Andren-Sandberg \u00c5; Duell EJ; Pancreatitisdiabetes- pancreatic cancer: Summary of an NIDDK-NCI workshop. Pancreas 2013,42(8)","journal-title":"Pancreas"},{"key":"ref=26","first-page":"27","volume":"32","author":"Domschke S.","year":"1985","unstructured":"Domschke S.; Stock K.P.; Pichl J.; Schneider M.U.; Domschke W.; Beta-cell reserve capacity in chronic pancreatitis. Hepatogastroenterology 1985,32,27-30","journal-title":"Hepatogastroenterology"},{"key":"ref=27","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.2337\/db16-1477","volume":"66","author":"Andersen D.K.","year":"2017","unstructured":"Andersen D.K.; Korc M.; Petersen G.M.; Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 2017,66(5),1103-1110","journal-title":"Diabetes"},{"key":"ref=28","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00268-006-0719-8","volume":"31","author":"Ballian N.","year":"2007","unstructured":"Ballian N.; Brunicardi F.C.; Islet vasculature as a regulator of endocrine pancreas function. World J Surg 2007,31(4),705-714","journal-title":"World J Surg"},{"key":"ref=29","doi-asserted-by":"crossref","first-page":"G56","DOI":"10.1152\/ajpcell.1981.240.1.C56","volume":"240","author":"Korc M.U.","year":"1981","unstructured":"Korc M.U.; Iwamoto Y.A.; Sankaran H.A.; Williams J.A.; Goldfine I.D.; Insulin action in pancreatic acini from streptozotocin-treated rats. I. Stimulation of protein synthesis. Am J Physiol 1981,240(1),G56-G62","journal-title":"Am J Physiol"},{"key":"ref=30","first-page":"G63","volume":"240","author":"Sankaran H.A.","year":"1981","unstructured":"Sankaran H.A.; Iwamoto Y.A.; Korc M.U.; Williams J.A.; Goldfine I.D.; Insulin action in pancreatic acini from streptozotocin-treated rats. II. Binding of I-insulin to receptors. Am J Physiol 1981,240(1),G63-G68","journal-title":"Am J Physiol"},{"key":"ref=31","author":"Gudipaty L.","year":"2015","unstructured":"Gudipaty L.; Rickels M.R.; Pancreatogenic (Type 3c) diabetes. Pancreapedia: Exocrine pancreas knowledge base Available from: 2015","journal-title":"Exocrine pancreas knowledge base"},{"key":"ref=32","doi-asserted-by":"crossref","first-page":"980","DOI":"10.2337\/diab.34.10.980","volume":"34","author":"Williams J.A.","year":"1985","unstructured":"Williams J.A.; Goldfine I.D.; The insulin-pancreatic acinar axis. Diabetes 1985,34(10),980-986","journal-title":"Diabetes"},{"key":"ref=33","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1007\/BF00427003","volume":"377","author":"Kloppel G.","year":"1978","unstructured":"Kloppel G.; Bommer G.; Commandeur G.; Heitz P.; The endocrine pancreas in chronic pancreatitis. Immunocytochemical and ultrastructural studies. Virchows Arch A 1978,377(2),157-174","journal-title":"Virchows Arch A"},{"key":"ref=34","doi-asserted-by":"crossref","first-page":"1764","DOI":"10.1007\/s10620-012-2086-7","volume":"57","author":"Sasikala M.","year":"2012","unstructured":"Sasikala M.; Talukdar R.; Radhika G.; Rao G.V.; Pradeep R.; Subramanyam C.; Reddy D.N.; \u03b2-Cell Dysfunction in Chronic Pancreatitis. Dig Dis Sci 2012,57(7),1764-1772","journal-title":"Dig Dis Sci"},{"key":"ref=35","first-page":"119","volume":"104","author":"Seymour N.E.","year":"1988","unstructured":"Seymour N.E.; Brunicardi F.C.; Chaiken R.L.; Reversal of abnormal glucose production after pancreatic resection by pancreatic polypeptide administration in man. Surgery 1988,104(2),119-129","journal-title":"Surgery"},{"key":"ref=36","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2147\/DMSO.S99701","volume":"9","author":"Makuc J.","year":"2016","unstructured":"Makuc J.; Management of pancreatogenic diabetes: challenges and solutions. Diabetes Metab Syndr Obes 2016,9,311-315","journal-title":"Diabetes Metab Syndr Obes"},{"key":"ref=37","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/BF01271165","volume":"23","author":"Andersen B.N.","year":"1982","unstructured":"Andersen B.N.; Krarup T.; Pedersen N.T.; Faber O.K.; Hagen C.; Worning H.; B cell function in patients with chronic pancreatitis and its relation to exocrine pancreatic function. Diabetologia 1982,23,86-89","journal-title":"Diabetologia"},{"key":"ref=38","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.regpep.2010.05.011","volume":"164","author":"Knop F.K.","year":"2010","unstructured":"Knop F.K.; Vilsboll T.; Larsen S.; Madsbad S.; Holst J.J.; Krarup T.; Glucagon suppression during OGTT worsens while suppression during IVGTT sustains alongside development of glucose intolerance in patients with chronic pancreatitis. Regul Pept 2010,164,144-150","journal-title":"Regul Pept"},{"key":"ref=39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000329188","volume":"11","author":"Cui Y.","year":"2011","unstructured":"Cui Y.; Andersen D.K.; Pancreatogenic diabetes: special considerations for management. Pancreatology 2011,11,279-294","journal-title":"Pancreatology"},{"key":"ref=40","doi-asserted-by":"crossref","first-page":"619","DOI":"10.2337\/diab.14.10.619","volume":"14","author":"Gepts W.","year":"1965","unstructured":"Gepts W.; Pathologic anatomy of the pancreas in juvenile diabetes mellitus. Diabetes 1965,14(10),619-633","journal-title":"Diabetes"},{"key":"ref=41","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1002\/dmr.5610030403","volume":"3","author":"Gepts W.","year":"1987","unstructured":"Gepts W.; In\u2019t Veld P.A.; Islet morphologic changes. Diabetes Metab Rev 1987,3(4),859-872","journal-title":"Diabetes Metab Rev"},{"key":"ref=42","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1159\/000085276","volume":"5","author":"Chari S.T.","year":"2005","unstructured":"Chari S.T.; Zapiach M.; Yadav D.; Rizza R.A.; \u03b2-cell function and insulin resistance evaluated by HOMA in pancreatic cancer subjects with varying degrees of glucose intolerance. Pancreatology 2005,5,229-233","journal-title":"Pancreatology"},{"key":"ref=43","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1053\/j.gastro.2012.08.044","volume":"143","author":"Aggarwal G.","year":"2012","unstructured":"Aggarwal G.; Ramachandran V.; Javeed N.; Adrenomedullin is upregulated in patients with pancreatic cancer and causes insulin resistance in \u03b2 cells and mice. Gastroenterology 2012,143,1510-1517","journal-title":"Gastroenterology"},{"key":"ref=44","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1152\/ajpendo.00213.2005","volume":"291","author":"Sekine N.","year":"2006","unstructured":"Sekine N.; Takano K.; Kimata-Hayashi N.; Kadowaki T.; Fujita T.; Adrenomedullin inhibits insulin exocytosis via pertussis toxin-sensitive G protein-coupled mechanism. Am J Physiol Endocrinol Metab 2006,291,E9-E14","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0007502","volume":"4","author":"Ramachandran V.","year":"2009","unstructured":"Ramachandran V.; Arumugam T.; Langley R.; The ADMR receptor mediates the effects of adrenomedullin on pancreatic cancer cells and on cells of the tumor microenvironment. PLoS One 2009,4","journal-title":"PLoS One"},{"key":"ref=46","doi-asserted-by":"crossref","first-page":"2666","DOI":"10.1158\/0008-5472.CAN-06-3362","volume":"67","author":"Ramachandran V.","year":"2007","unstructured":"Ramachandran V.; Arumugam T.; Hwang R.F.; Greenson J.K.; Simeone D.M.; Logsdon C.D.; Adrenomedullin is expressed in pancreatic cancer and stimulates cell proliferation and invasion in an autocrine manner via the adrenomedullin receptor, ADMR. Cancer Res 2007,67,2666-2675","journal-title":"Cancer Res"},{"key":"ref=47","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1002\/ijc.22596","volume":"121","author":"Keleg S.","year":"2007","unstructured":"Keleg S.; Kayed H.; Jiang X.; Adrenomedullin is induced by hypoxia and enhances pancreatic cancer cell invasion. Int J Cancer 2007,121,21-32","journal-title":"Int J Cancer"},{"key":"ref=48","first-page":"878","volume":"48","author":"Vlasakova Z.","year":"2002","unstructured":"Vlasakova Z.; Bartos V.; Spicak J.; Diabetes mellitus in chronic pancreatitis and insulin sensitivity. Vnitr Lek 2002,48,878-881","journal-title":"Vnitr Lek"},{"key":"ref=49","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/0026-0495(86)90239-8","volume":"35","author":"Yki-Jarvinen H.","year":"1986","unstructured":"Yki-Jarvinen H.; Kiviluoto T.; Taskinen M.R.; Insulin resistance is a prominent feature of patients with pancreatogenic diabetes. Metabolism 1986,35,718-727","journal-title":"Metabolism"},{"key":"ref=50","doi-asserted-by":"crossref","first-page":"346","DOI":"10.2337\/diab.31.4.346","volume":"31","author":"Nosadini R.","year":"1982","unstructured":"Nosadini R.; Del Prato S.; Tiengo A.; Insulin sensitivity, binding, and kinetics in pancreatogenic and type I diabetes. Diabetes 1982,31,346-355","journal-title":"Diabetes"},{"key":"ref=51","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/BF03348136","volume":"10","author":"Muggeo M.","year":"1987","unstructured":"Muggeo M.; Moghetti P.; Faronato P.P.; Insulin receptors on circulating blood cells from patients with pancreatogenic diabetes: a comparison with type I diabetes and normal subjects. J Endocrinol Invest 1987,10,311-319","journal-title":"J Endocrinol Invest"},{"key":"ref=52","first-page":"1707","volume":"49","author":"Malecka-Panas E.","year":"2002","unstructured":"Malecka-Panas E.; Gasiorowska A.; Kropiwnicka A.; Zlobinska A.; Drzewoski J.; Endocrine pancreatic function in patients after acute pancreatitis. Hepatogastroenterology 2002,49,1707-1712","journal-title":"Hepatogastroenterology"},{"key":"ref=53","first-page":"1","volume":"131","author":"Perusicov\u2019a J.","year":"1989","unstructured":"Perusicov\u2019a J.; Glucose tolerance and secretion of insulin in chronic pancreatitis. Acta Univ Carol Med Monogr 1989,131,1-92","journal-title":"Acta Univ Carol Med Monogr"},{"key":"ref=54","doi-asserted-by":"crossref","first-page":"G50","DOI":"10.1152\/ajpgi.00074.2016","volume":"311","author":"Pendharkar S.A.","year":"2016","unstructured":"Pendharkar S.A.; Asrani V.M.; Xiao A.Y.; Relationship between pancreatic hormones and glucose metabolism: a cross-sectional study in patients after acute pancreatitis. Am J Physiol Gastrointest Liver Physiol 2016,311,G50-G58","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"ref=55","first-page":"3566","volume":"81","author":"Brunicardi F.C.","year":"1996","unstructured":"Brunicardi F.C.; Chaiken R.L.; Ryan A.S.; Pancreatic polypeptide administration improves abnormal glucose metabolism in patients with chronic pancreatitis. J Clin Endocrinol Metab 1996,81(10),3566-3572","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=56","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0022-4804(89)90159-5","volume":"46","author":"Seymour N.E.","year":"1989","unstructured":"Seymour N.E.; Turk J.B.; Laster M.K.; In vitro hepatic insulin resistance in chronic pancreatitis in the rat. J Surg Res 1989,46(5),450-456","journal-title":"J Surg Res"},{"key":"ref=57","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0002-9610(99)80117-2","volume":"169","author":"Seymour N.E.","year":"1995","unstructured":"Seymour N.E.; Volpert A.R.; Lee E.L.; Andersen D.K.; Hernandez C.; Alterations in hepatocyte insulin binding in chronic pancreatitis: Effects of pancreatic polypeptide. Am J Surg 1995,169(1),105-110","journal-title":"Am J Surg"},{"key":"ref=58","first-page":"1128","volume":"106","author":"Goldstein JA","year":"1989","unstructured":"Goldstein JA; Kirwin JD; Seymour NE; Trachtenberg JE; Rademaker EA; Andersen DK; Reversal of in vitro hepatic insulin resistance in chronic pancreatitis by pancreatic polypeptide in the rat. Surgery 1989,106(6),1128-32-3.","journal-title":"Surgery"},{"key":"ref=59","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1177\/193229681100500629","volume":"5","author":"Rabiee A.","year":"2011","unstructured":"Rabiee A.; Galiatsatos P.; Salas-Carrillo R.; Thompson M.J.; Andersen D.K.; Elahi D.; Pancreatic polypeptide administration enhances insulin sensitivity and reduces the insulin requirement of patients on insulin pump therapy. J Diabetes Sci Technol 2011,5(6),1521-1528","journal-title":"J Diabetes Sci Technol"},{"key":"ref=60","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/nm1166","volume":"11","author":"Cai D.","year":"2005","unstructured":"Cai D.; Yuan M.; Frantz D.F.; Local and systemic insulin resistance resulting from hepatic activation of IKK-\u03b2 and NF-\u03baB. Nat Med 2005,11(2),183-190","journal-title":"Nat Med"},{"key":"ref=61","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1006\/bbrc.2001.4361","volume":"281","author":"Andersson A.K.","year":"2001","unstructured":"Andersson A.K.; Flodstr\u00f6m M.; Sandler S.; Cytokine-induced inhibition of insulin release from mouse pancreatic \u03b2-cells deficient in inducible nitric oxide synthase. Biochem Biophys Res Commun 2001,281(2),396-403","journal-title":"Biochem Biophys Res Commun"},{"key":"ref=62","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1089\/jir.2014.0082","volume":"35","author":"Pondugala P.K.","year":"2015","unstructured":"Pondugala P.K.; Sasikala M.; Guduru V.R.; Rebala P.; Reddy D.N.; Interferon-\u03b3 decreases nuclear localization of Pdx-1 and triggers \u03b2-cell dysfunction in chronic pancreatitis. J Interferon Cytokine Res 2015,35(7),523-529","journal-title":"J Interferon Cytokine Res"},{"key":"ref=63","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1463-1326.2009.01121.x","volume":"11","author":"Fujimoto K.","year":"2009","unstructured":"Fujimoto K.; Polonsky K.S.; Pdx1 and other factors that regulate pancreatic beta-cell survival. Diabetes Obes Metab 2009,11(Suppl. 4),30-37","journal-title":"Diabetes Obes Metab"},{"key":"ref=64","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/ajg.2010.32","volume":"105","author":"Huang H.","year":"2010","unstructured":"Huang H.; Dong X.; Kang M.X.; Novel blood biomarkers of pancreatic cancer-associated diabetes mellitus identified by peripheral blood-based gene expression profiles. Am J Gastroenterol 2010,105(7),1661-1669","journal-title":"Am J Gastroenterol"},{"key":"ref=65","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1038\/nrgastro.2013.49","volume":"10","author":"Sah R.P.","year":"2013","unstructured":"Sah R.P.; Nagpal S.J.S.; Mukhopadhyay D.; Chari S.T.; New insights into pancreatic cancer-induced paraneoplastic diabetes. Nat Rev Gastroenterol Hepatol 2013,10(7),423-433","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"ref=66","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1002\/bjs.1800800841","volume":"80","author":"Permert J.","year":"1993","unstructured":"Permert J.; Ihse I.; Jorfeldt L.; von Schenck H.; Arnquist H.J.; Larsson J.; Improved glucose metabolism after subtotal pancreatectomy for pancreatic cancer. Br J Surg 1993,80(8),1047-1050","journal-title":"Br J Surg"},{"key":"ref=67","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1097\/00006676-199707000-00009","volume":"15","author":"Permert J.","year":"1997","unstructured":"Permert J.; Larsson J.; Fruin A.B.; Tatemoto K.; Herrington M.K.; Adrian T.E.; Islet hormone secretion in pancreatic cancer patients with diabetes. Pancreas 1997,15(1),60-68","journal-title":"Pancreas"},{"key":"ref=68","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJM199402033300503","volume":"330","author":"Permert J.","year":"1994","unstructured":"Permert J.; Larsson J.; Westermark G.T.; Islet amyloid polypeptide in patients with pancreatic cancer and diabetes. N Engl J Med 1994,330(5),313-318","journal-title":"N Engl J Med"},{"key":"ref=69","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1016\/j.bcp.2006.05.017","volume":"72","author":"Gebhardt C.","year":"2006","unstructured":"Gebhardt C.; N\u00e9meth J.; Angel P.; Hess J.; S100A8 and S100A9 in inflammation and cancer. Biochem Pharmacol 2006,72(11),1622-1631","journal-title":"Biochem Pharmacol"},{"key":"ref=70","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1097\/00006676-200411000-00007","volume":"29","author":"Pfeffer F.","year":"2004","unstructured":"Pfeffer F.; Koczan D.; Adam U.; Expression of connexin26 in islets of Langerhans is associated with impaired glucose tolerance in patients with pancreatic adenocarcinoma. Pancreas 2004,29(4),284-290","journal-title":"Pancreas"},{"key":"ref=71","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1083\/jcb.201301001","volume":"202","author":"Liou G.Y.","year":"2013","unstructured":"Liou G.Y.; D\u00f6ppler H.; Necela B.; Macrophage-secreted cytokines drive pancreatic acinar-to-ductal metaplasia through NF-\u03baB and MMPs. J Cell Biol 2013,202(3),563-577","journal-title":"J Cell Biol"},{"key":"ref=72","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1158\/0008-5472.CAN-07-0175","volume":"67","author":"Clark C.E.","year":"2007","unstructured":"Clark C.E.; Hingorani S.R.; Mick R.; Combs C.; Tuveson D.A.; Vonderheide R.H.; Dynamics of the immune reaction to pancreatic cancer from inception to invasion. Cancer Res 2007,67(19),9518-9527","journal-title":"Cancer Res"},{"key":"ref=73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.cca.2006.03.027","volume":"372","author":"Basso D.","year":"2006","unstructured":"Basso D.; Greco E.; Fogar P.; Pancreatic cancer-derived S-100A8 N-terminal peptide: A diabetes cause? Clin Chim Acta 2006,372(1-2),120-128","journal-title":"Clin Chim Acta"},{"key":"ref=74","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.jprot.2013.03.031","volume":"84","author":"Wang W.S.","year":"2013","unstructured":"Wang W.S.; Liu X.H.; Liu L.X.; Jin D.Y.; Yang P.Y.; Wang X.L.; Identification of proteins implicated in the development of pancreatic cancer-associated diabetes mellitus by iTRAQ-based quantitative proteomics. J Proteomics 2013,84,52-60","journal-title":"J Proteomics"},{"key":"ref=75","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cca.2016.02.018","volume":"456","author":"Moz S.","year":"2016","unstructured":"Moz S.; Basso D.; Padoan A.; Blood expression of matrix metalloproteinases 8 and 9 and of their inducers S100A8 and S100A9 supports diagnosis and prognosis of PDAC-associated diabetes mellitus. Clin Chim Acta 2016,456,24-30","journal-title":"Clin Chim Acta"},{"key":"ref=76","doi-asserted-by":"crossref","first-page":"4159","DOI":"10.4049\/jimmunol.157.9.4159","volume":"157","author":"Sar\u00e9n P.","year":"1996","unstructured":"Sar\u00e9n P.; Welgus H.G.; Kovanen P.T.; TNF-alpha and IL-1beta selectively induce expression of 92-kDa gelatinase by human macrophages. J Immunol 1996,157(9),4159-4165","journal-title":"J Immunol"},{"key":"ref=77","doi-asserted-by":"crossref","first-page":"4916","DOI":"10.4049\/jimmunol.164.9.4916","volume":"164","author":"Xu K.","year":"2000","unstructured":"Xu K.; Geczy C.L.; IFN-gamma and TNF regulate macrophage expression of the chemotactic S100 protein S100A8. J Immunol 2000,164(9),4916-4923","journal-title":"J Immunol"},{"key":"ref=78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/1479-5876-4-48","volume":"4","author":"Lewis A.M.","year":"2006","unstructured":"Lewis A.M.; Varghese S.; Xu H.; Alexander H.R.; Interleukin-1 and cancer progression: the emerging role of interleukin-1 receptor antagonist as a novel therapeutic agent in cancer treatment. J Transl Med 2006,4(1),48","journal-title":"J Transl Med"},{"key":"ref=79","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.regpep.2004.08.004","volume":"15","author":"Creutzfeldt W.","year":"2005","unstructured":"Creutzfeldt W.; The [pre-] history of the incretin concept. Regul Pept 2005,15,87-91","journal-title":"Regul Pept"},{"key":"ref=80","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1042\/BST0340774","volume":"34","author":"Flatt P.R.","year":"2006","unstructured":"Flatt P.R.; Green B.D.; Nutrient regulation of pancreatic beta-cell function in diabetes: problems and potential solutions. Biochem Soc Trans 2006,34,774-778","journal-title":"Biochem Soc Trans"},{"key":"ref=81","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1517\/14656566.7.15.2095","volume":"7","author":"Stonehouse A.H.","year":"2006","unstructured":"Stonehouse A.H.; Holcombe J.H.; Kendall D.M.; Management of type 2 diabetes: the role of incretin mimetics. Expert Opin Pharmacother 2006,7,2095-2105","journal-title":"Expert Opin Pharmacother"},{"key":"ref=82","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2337\/diabetes.49.5.741","volume":"49","author":"Stoffers D.A.","year":"2000","unstructured":"Stoffers D.A.; Kieffer T.J.; Hussain M.A.; Insulinotropic glucagon-like peptide-1 agonists stimulate expression of homeodomain protein IDX-1 and increase islet size in mouse pancreas. Diabetes 2000,49,741-748","journal-title":"Diabetes"},{"key":"ref=83","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00275269","volume":"19","author":"Ebert R.","year":"1980","unstructured":"Ebert R.; Creutzfeldt W.; Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia 1980,19,198-204","journal-title":"Diabetologia"},{"key":"ref=84","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1210\/jc.2010-2460","volume":"96","author":"Kuo P.","year":"2011","unstructured":"Kuo P.; Stevens J.E.; Russo A.; Gastric emptying, incretin hormone secretion and postprandial glycemia in cystic fibrosis\u2014 effects of pancreatic enzyme supplementation. J Clin Endocrinol Metab 2011,96,851-855","journal-title":"J Clin Endocrinol Metab"},{"key":"ref=85","doi-asserted-by":"crossref","first-page":"E324","DOI":"10.1152\/ajpendo.00059.2006","volume":"292","author":"Knop F.K.","year":"2007","unstructured":"Knop F.K.; Vilsb\u00f8ll T.; Larsen S.; Increased postprandial responses of GLP-1 and GIP in patients with chronic pancreatitis and steatorrhea following pancreatic enzyme substitution. Am J Physiol Endocrinol Metab 2007,292,E324-E330","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"ref=86","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1159\/000243729","volume":"10","author":"Hornum M.","year":"2010","unstructured":"Hornum M.; Pedersen J.F.; Larsen S.; Olsen O.; Holst J.J.; Knop F.K.; Increased postprandial response of glucagon-like peptide-2 in patients with chronic pancreatitis and pancreatic exocrine insufficiency. Pancreatology 2010,10,201-217","journal-title":"Pancreatology"},{"key":"ref=87","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.1056\/NEJMoa0804742","volume":"359","author":"Meigs J.B.","year":"2008","unstructured":"Meigs J.B.; Shrader P.; Sullivan L.M.; Genotype score in addition to common risk factors for prediction of type 2 diabetes. N Engl J Med 2008,359,2208-2219","journal-title":"N Engl J Med"},{"key":"ref=88","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1089\/dia.2009.0051","volume":"11","author":"Liu Q.C.","year":"2009","unstructured":"Liu Q.C.; Zhuang Z.H.; Zeng K.; Cheng Z.J.; Gao F.; Wang Z.Q.; Prevalence of pancreatic diabetes in patients carrying mutations or polymorphisms of the PRSS1 gene in the Han population. Diabetes Technol Ther 2009,11(12),799-804","journal-title":"Diabetes Technol Ther"},{"key":"ref=89","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1126\/science.1171202","volume":"324","author":"Jones S.","year":"2009","unstructured":"Jones S.; Hruban R.H.; Kamiyama M.; Exomic sequencing identifies PALB2 as a pancreatic cancer susceptibility gene. Science 2009,324(5924),217","journal-title":"Science"},{"key":"ref=90","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1158\/2159-8290.CD-11-0194","volume":"2","author":"Roberts N.J.","year":"2012","unstructured":"Roberts N.J.; Jiao Y.; Yu J.; ATM mutations in patients with hereditary pancreatic cancer. Cancer Discov 2012,2,41-46","journal-title":"Cancer Discov"},{"key":"ref=91","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1158\/1055-9965.EPI-15-0455","volume":"25","author":"Hu C.","year":"2016","unstructured":"Hu C.; Hart S.N.; Bamlet W.R.; Prevalence of pathogenic mutations in cancer predisposition genes among pancreatic cancer patients. Cancer Epidemiol Biomarkers Prev 2016,25,207-211","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=92","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1158\/1055-9965.EPI-09-0557","volume":"18","author":"Wang L.","year":"2009","unstructured":"Wang L.; Brune K.A.; Visvanathan K.; Elevated cancer mortality in the relatives of patients with pancreatic cancer. Cancer Epidemiol Biomarkers Prev 2009,18,2829-2834","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"ref=93","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/mc.20855","volume":"51","author":"Klein A.P.","year":"2012","unstructured":"Klein A.P.; Genetic susceptibility to pancreatic cancer. Mol Carcinog 2012,51,14-24","journal-title":"Mol Carcinog"},{"key":"ref=94","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1097\/PPO.0b013e318278c4a6","volume":"18","author":"Solomon S.","year":"2012","unstructured":"Solomon S.; Das S.; Brand R.; Whitcomb D.C.; Inherited pancreatic cancer syndromes. Cancer J 2012,18,485-491","journal-title":"Cancer J"},{"key":"ref=95","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1136\/gut.2005.074534","volume":"54","author":"McWilliams R.","year":"2005","unstructured":"McWilliams R.; Highsmith W.E.; Rabe K.G.; Cystic fibrosis transmembrane regular gene carrier status is a risk factor for young onset pancreatic adenocarcinoma. Gut 2005,54,661-662","journal-title":"Gut"},{"key":"ref=96","doi-asserted-by":"crossref","first-page":"S13","DOI":"10.2337\/dc16-S005","volume":"39","year":"2016","unstructured":"American Diabetes Association AD Classification and diagnosis of diabetes. Diabetes Care 2016,39(Suppl. 1),S13-S22","journal-title":"Diabetes Care"},{"key":"ref=97","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ejim.2012.12.017","volume":"24","author":"Ewald N.","year":"2013","unstructured":"Ewald N.; Bretzel R.G.; Diabetes mellitus secondary to pancreatic diseases (Type 3c) \u2014 Are we neglecting an important disease? Eur J Intern Med 2013,24(3),203-206","journal-title":"Eur J Intern Med"},{"key":"ref=98","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/diacare.8.4.323","volume":"8","author":"Couet C.","year":"1985","unstructured":"Couet C.; Genton P.; Pointel J.P.; The prevalence of retinopathy is similar in diabetes mellitus secondary to chronic pancreatitis with or without pancreatectomy and in idiopathic diabetes mellitus. Diabetes Care 1985,8(4),323-328","journal-title":"Diabetes Care"},{"key":"ref=99","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/ejcn.2016.127","volume":"71","author":"Duggan S.N.","year":"2017","unstructured":"Duggan S.N.; Ewald N.; Kelleher L.; Griffin O.; Gibney J.; Conlon K.C.; The nutritional management of type 3c (pancreatogenic) diabetes in chronic pancreatitis. Eur J Clin Nutr 2017,71(1),3-8","journal-title":"Eur J Clin Nutr"},{"key":"ref=100","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3109\/00365527709180943","volume":"12","author":"Linde J.","year":"1977","unstructured":"Linde J.; Nilsson L.H.; Barany F.R.; Diabetes and hypoglycemia in chronic pancreatitis. Scand J Gastroenterol 1977,12(3),369-373","journal-title":"Scand J Gastroenterol"},{"key":"ref=101","doi-asserted-by":"crossref","first-page":"570","DOI":"10.2337\/diacare.6.6.570","volume":"6","author":"Tiengo A.","year":"1983","unstructured":"Tiengo A.; Segato T.; Briani G.; The presence of retinopathy in patients with secondary diabetes following pancreatectomy or chronic pancreatitis. Diabetes Care 1983,6(6),570-574","journal-title":"Diabetes Care"},{"key":"ref=102","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/0891-6632(88)90030-X","volume":"2","author":"Briani G.","year":"1988","unstructured":"Briani G.; Riva F.; Midena E.; Prevalence of microangiopathic complications in hyperglycemia secondary to pancreatic disease. J Diabet Complications 1988,2(1),50-52","journal-title":"J Diabet Complications"},{"key":"ref=103","first-page":"540","volume":"20","author":"Ziegler O.","year":"1994","unstructured":"Ziegler O.; Candiloros H.; Guerci B.; Got I.; Crea T.; Drouin P.; Lower-extremity arterial disease in diabetes mellitus due to chronic pancreatitis. Diabete Metab 1994,20(6),540-545","journal-title":"Diabete Metab"},{"key":"ref=104","doi-asserted-by":"crossref","first-page":"F9","DOI":"10.1530\/ERC-12-0105","volume":"19","author":"Cui Y.","year":"2012","unstructured":"Cui Y.; Andersen D.K.; Diabetes and pancreatic cancer. Endocr Relat Cancer 2012,19(5),F9-F26","journal-title":"Endocr Relat Cancer"},{"key":"ref=105","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1111\/j.1440-1746.2011.06938.x","volume":"27","author":"Liao K.F.","year":"2012","unstructured":"Liao K.F.; Lai S.W.; Li C.I.; Chen W.C.; Diabetes mellitus correlates with increased risk of pancreatic cancer: A population-based cohort study in Taiwan. J Gastroenterol Hepatol 2012,27(4),709-713","journal-title":"J Gastroenterol Hepatol"},{"key":"ref=106","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2015.44","volume":"6","author":"Munigala S.","year":"2015","unstructured":"Munigala S.; Singh A.; Gelrud A.; Agarwal B.; Predictors for pancreatic cancer diagnosis following new-onset diabetes mellitus. Clin Transl Gastroenterol 2015,6(10)","journal-title":"Clin Transl Gastroenterol"},{"key":"ref=107","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1111\/j.1463-1326.2012.01667.x","volume":"14","author":"Brodovicz K.G.","year":"2012","unstructured":"Brodovicz K.G.; Kou T.D.; Alexander C.M.; Impact of diabetes duration and chronic pancreatitis on the association between type 2 diabetes and pancreatic cancer risk. Diabetes Obes Metab 2012,14(12),1123-1128","journal-title":"Diabetes Obes Metab"},{"key":"ref=108","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2337\/dc08-9025","volume":"32","author":"Nathan D.M.","year":"2009","unstructured":"Nathan D.M.; Buse J.B.; Davidson M.B.; Medical management of hyperglycemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement of the american diabetes association and the european association for the study of diabetes. Diabetes Care 2009,32(1),193-203","journal-title":"Diabetes Care"},{"key":"ref=109","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/j.pan.2013.05.002","volume":"13","author":"Rickels M.R.","year":"2013","unstructured":"Rickels M.R.; Bellin M.; Toledo F.G.; Detection, evaluation and treatment of diabetes mellitus in chronic pancreatitis: Recommendations from PancreasFest 2012. Pancreatology 2013,13(4),336-342","journal-title":"Pancreatology"},{"key":"ref=110","volume":"3","author":"Lund S.S.","year":"2008","unstructured":"Lund S.S.; Tarnow L.; Astrup A.S.; Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A Randomized Study. PLoS One 2008,3(10)","journal-title":"PLoS One"},{"key":"ref=111","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.diabres.2014.04.007","volume":"106","author":"Wang Z.","year":"2014","unstructured":"Wang Z.; Lai S.T.; Xie L.; Metformin is associated with reduced risk of pancreatic cancer in patients with type 2 diabetes mellitus: A systematic review and meta-analysis. Diabetes Res Clin Pract 2014,106(1),19-26","journal-title":"Diabetes Res Clin Pract"},{"key":"ref=112","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1053\/j.gastro.2009.04.013","volume":"137","author":"Li D.","year":"2009","unstructured":"Li D.; Yeung S.J.; Hassan M.M.; Konopleva M.; Abbruzzese J.L.; Antidiabetic therapies affect risk of pancreatic cancer. Gastroenterology 2009,137(2),482-488","journal-title":"Gastroenterology"},{"key":"ref=113","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1136\/bmj.38415.708634.F7","volume":"330","author":"Evans J.M.","year":"2005","unstructured":"Evans J.M.; Donnelly L.A.; Emslie-Smith A.M.; Alessi D.R.; Morris A.D.; Metformin and reduced risk of cancer in diabetic patients. BMJ 2005,330(7503),1304-1305","journal-title":"BMJ"},{"key":"ref=114","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1038\/ajg.2013.7","volume":"108","author":"Singh S.","year":"2013","unstructured":"Singh S.; Singh P.P.; Singh A.G.; Murad M.H.; McWilliams R.R.; Chari S.T.; Anti-diabetic medications and risk of pancreatic cancer in patients with diabetes mellitus: A systematic review and meta-analysis. Am J Gastroenterol 2013,108(4),510-519","journal-title":"Am J Gastroenterol"},{"key":"ref=115","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","volume":"54","author":"Maida A.","year":"2011","unstructured":"Maida A.; Lamont B.J.; Cao X.; Drucker D.J.; Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice. Diabetologia 2011,54(2),339-349","journal-title":"Diabetologia"},{"key":"ref=116","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1158\/1078-0432.CCR-11-2994","volume":"18","author":"Sadeghi N.","year":"2012","unstructured":"Sadeghi N.; Abbruzzese J.L.; Yeung S.C.J.; Hassan M.; Li D.; Metformin use is associated with better survival of diabetic patients with pancreatic cancer. Clin Cancer Res 2012,18(10),2905-2912","journal-title":"Clin Cancer Res"},{"key":"ref=117","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.nano.2012.12.005","volume":"9","author":"Banerjee A.","year":"2013","unstructured":"Banerjee A.; Onyuksel H.; A novel peptide nanomedicine for treatment of pancreatogenic diabetes. Nanomedicine 2013,9(6),722-728","journal-title":"Nanomedicine"},{"key":"ref=118","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/dc18-ti01","volume":"41","year":"2018","unstructured":"American Diabetes Association Standards of medical care in diabetes 2018. Diabetes Care 2018,41(Suppl. 1),1-172","journal-title":"Diabetes Care"},{"key":"ref=119","first-page":"15","author":"Conlon K.C.","year":"2017","unstructured":"Conlon K.C.; Duggan S.N.; Pancreatogenic type 3c diabetes: underestimated, underappreciated and poorly managed. Pract Gastroenterol 2017,15","journal-title":"Pract Gastroenterol"},{"key":"ref=120","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14740338.2012.691963","volume":"11","author":"Kung J.","year":"2012","unstructured":"Kung J.; Henry R.R.; Thiazolidinedione safety. Expert Opin Drug Saf 2012,11(4),565-579","journal-title":"Expert Opin Drug Saf"},{"key":"ref=121","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.2337\/db09-1899","volume":"59","author":"Meier J.J.","year":"2010","unstructured":"Meier J.J.; Nauck M.A.; Is the diminished incretin effect in type 2 diabetes just an epi-phenomenon of impaired beta-cell function? Diabetes 2010,59(5),1117-1125","journal-title":"Diabetes"},{"key":"ref=122","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1464-5491.1999.00047.x","volume":"16","author":"Riccardi G.","year":"1999","unstructured":"Riccardi G.; Giacco R.; Parillo M.; Efficacy and safety of acarbose in the treatment of Type 1 diabetes mellitus: a placebo-controlled, double-blind, multicentre study. Diabet Med 1999,16(3),228-232","journal-title":"Diabet Med"},{"key":"ref=123","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","volume":"29","author":"Bowker S.L.","year":"2006","unstructured":"Bowker S.L.; Majumdar S.R.; Veugelers P.; Johnson J.A.; Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin. Diabetes Care 2006,29(2),254-258","journal-title":"Diabetes Care"},{"key":"ref=124","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/BF00275269","volume":"19","author":"Ebert R.","year":"1980","unstructured":"Ebert R.; Creutzfeldt W.; Reversal of impaired GIP and insulin secretion in patients with pancreatogenic steatorrhea following enzyme substitution. Diabetologia 1980,19(3),198-204","journal-title":"Diabetologia"},{"key":"ref=125","first-page":"1991","volume":"32","author":"Klapdor S.","year":"2012","unstructured":"Klapdor S.; Richter E.; Klapdor R.; Vitamin D status and per-oral vitamin D supplementation in patients suffering from chronic pancreatitis and pancreatic cancer disease. Anticancer Res 2012,32(5),1991-1998","journal-title":"Anticancer Res"},{"key":"ref=126","first-page":"24","volume":"118","author":"Duggan S.N.","year":"2013","unstructured":"Duggan S.N.; Conlon K.C.; A practical guide to the nutritional management of chronic pancreatitis. Pract Gastroenterol 2013,118,24-32","journal-title":"Pract Gastroenterol"},{"key":"ref=127","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.2337\/dc16-S008","volume":"39","year":"2016","unstructured":"American Diabetes Association AD Glycemic targets. Diabetes Care 2016,39(Suppl. 1),S39-S46","journal-title":"Diabetes Care"},{"key":"ref=128","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diabres.2011.12.010","volume":"96","author":"Joubert M.","year":"2012","unstructured":"Joubert M.; Reznik Y.; Personal continuous glucose monitoring (CGM) in diabetes management: Review of the literature and implementation for practical use. Diabetes Res Clin Pract 2012,96(3),294-305","journal-title":"Diabetes Res Clin Pract"}],"container-title":["Current Diabetes Reviews"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/eurekaselect.com\/article\/download\/169010","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,12]],"date-time":"2023-09-12T23:30:38Z","timestamp":1694561438000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.eurekaselect.com\/169010\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,8,20]]},"references-count":128,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,8,20]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1573399815666190115145702","relation":{},"ISSN":["1573-3998"],"issn-type":[{"value":"1573-3998","type":"print"}],"subject":[],"published":{"date-parts":[[2019,8,20]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2018-06-07","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2018-11-02","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-08","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-08-20","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}